The effect of H1 antagonists carebastine and olopatadine on histamine induced expression of CC chemokines in cultured human nasal epithelial cells

Allergology International

Volumn 56, Issue 2, 2007, Pages 171-177

  Yamauchi, Yoko ^a   Fujikura, Terumichi ^b   Shimosawa, Tatsuo ^c  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Allergic rhinitis; Carebastine; CC chemokine; Histamine; Human nasal epithelial cells; Monocyte chemotactic protein 1; Olopatadine; RANTES

Indexed keywords

ANTIHISTAMINIC AGENT; BETA CHEMOKINE; CAREBASTINE; CORTICOSTEROID DERIVATIVE; HISTAMINE; MONOCYTE CHEMOTACTIC PROTEIN 1; OLOPATADINE; RANTES;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INCUBATION TIME; MALE; NOSE ALLERGY; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SCHOOL CHILD; T LYMPHOCYTE;

EID: 34250795089     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-06-446     Document Type: Article

References (38)

1. Nickel R, Beck LA, Stellato C, Schleimer RP. Chemokines and allergic disease. J. Allergy Clin. Immunol. 1999;104: 723-742.
2. Baraniuk JN. Pathogenesis of allergic rhinitis. J. Allergy Clin. Immunol. 1997;99:S763-772.
3. Lordan JL, Holgate ST. H1-antihistamines in asthma. Clin. Allergy Immunol. 2002;17:221-248.
4. Iliopoulos O, Baroody FM, Naclerio RM, Bochner BS, Kagey-Sobotka A, Lichtenstein LM. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J. Immunol. 1992;148:2223-2228.
5. Howarth PH, Salagean M, Dokic D. Allergic rhinitis: not purely a histamine-related disease. Allergy 2000;55(Suppl 64):7-16.
6. Campbell A, Chanal I, Czarlewski W, Michel FB, Bousquet J. Reduction of soluble ICAM-1 levels in nasal secretion by H1-blockers in seasonal allergic rhinitis. Allergy 1997;52:1022-1025.
7. Fujikura T, Shimosawa T, Yakuo I. Regulatory effect of histamine H1 receptor antagonist on the expression of messenger RNA encoding CC chemokines in the human nasal mucosa. J. Allergy Clin. Immunol. 2001;107:123- 128.
8. Otsuka H, Kusumi T, Kanai S, Koyama M, Kuno Y, Takizawa R. Stem cell factor mRNA expression and production in human nasal epithelial cells: contribution to the accumulation of mast cells in the nasal epithelium of allergy. J. Allergy Clin. Immunol. 1998;102:757-764.
9. Calderon MA, Devalia JL, Prior AJ, Sapsford RJ, Davies RJ. A comparison of cytokine release from epithelial cells cultured from nasal biopsy specimens of atopic patients with and without rhinitis and nonatopic subjects without rhinitis. J. Allergy Clin. Immunol. 1997;99:65-76.
10. Takeuchi K, Kishioka C, Ishinaga H, Sakakura Y, Majima Y. Histamine alters gene expression in cultured human nasal epithelial cells. J. Allergy Clin. Immunol. 2001;107: 310-314.
11. Weimer LK, Gamache DA, Yanni JM. Histamine-stimulated cytokine secretion from human conjunctival epithelial cells: inhibition by the histamine H1 antagonist emedastine. Int. Arch. Allergy Immunol. 1998;115:288- 293.
12. Jeannin P, Delneste Y, Gosset P et al. Histamine induces interleukin-8 secretion by endothelial cells. Blood 1994; 84:2229-2233.
13. Takizawa H, Ohtoshi T, Kikutani T et al. Histamine activates bronchial epithelial cells to release inflammatory cytokines in vitro. Int. Arch. Allergy Immunol. 1995;108: 260-267.
14. Yanni JM, Weimer LK, Sharif NA, Xu SX, Gamache DA, Spellman JM. Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs. Arch. Ophthalmol. 1999;117:643-647.
15. Vignola AM, Campbell AM, Chanez P et al. Activation by histamine of bronchial epithelial cells from nonasthmatic subjects. Am. J. Respir. Cell Mol. Biol. 1993;9:411-417.
16. Ciprandi G, Pronzato C, Ricca V, Varese P, Del Giacco GS, Canonica GW. Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy. Clin. Exp. Allergy 1995;25: 871-878.
17. Abdelaziz MM, Devalia JL, Khair OA, Bayram H, Prior AJ, Davies RJ. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis. J. Allergy Clin. Immunol. 1998;101: 410-420.
18. Iriyoshi N, Takeuchi K, Yuta A, Ukai K, Sakakura Y. Increased expression of histamine H1 receptor mRNA in allergic rhinitis. Clin. Exp. Allergy 1996;26:379-385.
19. Hamano N, Terada N, Maesako K et al. Expression of histamine receptors in nasal epithelial cells and endothelial cells - the effects of sex hormones. Int. Arch. Allergy Immunol. 1998;115:220-227.
20. Nakaya M, Takeuchi N, Kondo K. Immunohistochemical localization of histamine receptor subtypes in human inferior turbinates. Ann. Otol. Rhinol. Laryngol. 2004;113: 552-557.
21. Okayama M, Baraniuk JN, Hausfeld JN, Merida M, Kaliner MA. Characterization and autoradiographic localization of histamine H1 receptors in human nasal turbinates. J. Allergy Clin. Immunol. 1992;89:1144- 1150.
22. Ponath PD, Qin S, Ringler DJ et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 1996;97:604-612.
23. Uguccioni M, Mackay CR, Ochensberger B et al. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J. Clin. Invest. 1997;100:1137-1143.
24. Baggiolini M, Dahinden CA. CC chemokines in allergic inflammation. Immunol. Today 1994;15:127-133.
25. Dahinden CA, Geiser T, Brunner T et al. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J. Exp. Med. 1994;179: 751-756.
26. Terada N, Gorai S, Jeong KW, Nomura T, Numata T, Konno A. Mechanisms of eosinophilic inflammation in the mucosa of the nasal cavity and paranasal sinus. Allergol. Int. 2001;50:273-279.
27. Fujikura T, Otsuka H. Monocyte chemotactic and activating factor/monocyte chemoattractant protein-1-mediated histamine release from human nasal mucosa. Arch. Otolaryngol. Head Neck Surg. 1998;124:1331-1335.
28. Bayram H, Devalia JL, Khair OA et al. Effect of loratadine on nitrogen dioxide-induced changes in electrical resistance and release of inflammatory mediators from cultured human bronchial epithelial cells. J. Allergy Clin. Immunol. 1999;104:93-99.
29. Arnold R, Rihoux J, Konig W. Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549). Clin. Exp. Allergy 1999;29:1681-1691.
30. Weimer LK, Gamache DA, Yanni JM. Histamine-stimulated cytokine secretion from human conjunctival epithelial cells: inhibition by the histamine H1 antagonist emedastine. Int. Arch. Allergy Immunol. 1998;115:288- 293.
31. Church MK. H (1)-antihistamines and inflammation. Clin. Exp. Allergy 2001;31:1341-1343.
32. Assanasen P, Naclerio RM. Antiallergic anti-inflammatory effects of H1-antihistamines in humans. Clin. Allergy Immunol. 2002;17:101- 139.
33. Eda R, Townley RG, Hopp RJ. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide. Ann. Allergy 1994;73:154-160.
34. Busse W, Randlev B, Sedgwick J. The effect of azelastine on neutrophil and eosinophil generation of superoxide. J. Allergy Clin. Immunol. 1989;83:400-405.
35. Kempuraj D, Huang M, Kandere-Grzybowska K et al. Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells. Int. Arch. Allergy Immunol. 2003;132:231-239.
36. Ciprandi G, Buscaglia S, Pesce G et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J. Allergy Clin. Immunol. 1995;96:971-979.
37. Ciprandi G, Ricca V, Passalacqua G et al. Seasonal rhinitis and azelastine: long- or short-term treatment? J. Allergy Clin. Immunol. 1997;99:301-307.
38. Holgate ST, Canonica GW, Simons FE et al. Consensus Group on New-Generation Antihistamines. Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations. Clin. Exp. Allergy 2003; 33:1305-1324.